Copyright yourstory
From Bolt.Earth’s EV revolution to Neulife’s funding, YourStory brings you the latest from India’s tech and impact ecosystem. Featured stories How Bolt.Earth is driving India’s EV revolution with an Airbnb-style model In India, electric vehicles (EVs) are no longer a distant dream. They are becoming a popular choice among people, especially in urban areas, with adoption steadily picking up in Tier II and Tier III cities as well. As EV usage expands, the demand for a reliable charging ecosystem has seen an uptick, driving the development of infrastructure across apartment complexes, office parking spaces, and public areas. From screen recordings to studio-quality videos: How Trupeer.ai is democratising software content creation For software teams, creating product tutorials, onboarding guides, or internal training videos takes both time and money. The process is chaotic as live sessions require coordination, screen recordings appear unpolished, and hiring agencies or studios can cost thousands of dollars. Trupeer.ai, a Bengaluru-based startup, is changing this. Founded by Shivali Goyal and Pritish Gupta, the startup's AI-powered platform transforms simple screen recordings into professional-quality videos and step-by-step documentation in seconds. Latest news Neulife raises $1M in seed round led by Subhkam Ventures and Singularity Ventures Mumbai-based Neulife, a protein-focused performance nutrition brand, has raised $1 million in its maiden seed funding round co-led by Subhkam Ventures and Singularity Ventures. The round also saw participation from Sunicon Ventures, Cosma Ventures, and select high-net-worth individuals (HNIs). Prior to this, Neulife was entirely bootstrapped. The company said the funds will be used to drive product innovation, enhance research and clinical trials, expand its protein product portfolio, and support global growth initiatives. Founded in 2014 by Samit Gupta, a fitness industry veteran recognised as one of the pioneers of India’s sports nutrition market, Neulife focuses on developing scientifically validated, metabolically superior protein formulations. The company launched its direct-to-consumer (D2C) brand in 2022, marking a strategic shift towards catering to a growing base of health-conscious consumers seeking clean and evidence-based nutrition products. Beyond Next Ventures invests in AI video startup FinalLayer Beyond Next Ventures Inc. (BNV), Japan’s leading DeepTech-focused venture capital firm, has invested in FinalLayer, an AI infrastructure startup that aims to transform how professionals and creators produce video content. The deal marks the second investment from Beyond Next Ventures India 1 Investment Partnership, the firm’s maiden India-dedicated fund that backs early-stage entrepreneurs building globally competitive deep-tech ventures. FinalLayer is building next-generation AI agents that streamline the video creation process—from discovery and editing to storytelling—by operating at the intersection between foundational AI models and end-user applications. Its technology enables scalable, context-aware tools that enhance human creativity through intelligent automation. The company’s platform has seen rapid adoption, drawing more than 10,000 users within 10 weeks of its launch. Indian Cancer Society and Jain University host ‘CancaWare 2025 The Indian Cancer Society (ICS), Bengaluru, in collaboration with the School of Allied Health Sciences (SAHS) at Jain (Deemed-to-be University), hosted CancaWare 2025 – Relay for Life, a four-day awareness initiative dedicated to cancer prevention, early detection, and survivor support. The event, supported by AstraZeneca India, was held from October 13 to 16, 2025, at the university campus. The program combined student-led initiatives, expert talks, and community engagement sessions, underscoring the role of awareness as the first step in combating cancer. The event opened with “Canvas of Courage,” a T-shirt painting competition, and “Echoes of Strength,” a slogan-writing contest—both celebrating creativity and resilience. Over the following days, students participated in documentary challenges, street plays (Nukkad Natak), quizzes, and interactive stalls designed to educate peers and the public about cancer risk factors, preventive lifestyle habits, and the importance of early screening. Ramco Systems signs MoU with The ePlane Company for digital fleet management of eVTOL aircraft Global aviation software provider Ramco Systems has signed a Memorandum of Understanding (MoU) with The ePlane Company (Ubifly Technologies Pvt Ltd), a Chennai-based urban air mobility startup developing India’s first electric air taxi, the ePlane e200X. The agreement lays the groundwork for ePlane to deploy Ramco Aviation Software for the end-to-end lifecycle management of its e200X fleet, covering air taxi, air ambulance, and air cargo operations. As the e200X moves through certification and regulatory approvals, the two companies will collaborate to implement the aviation software suite in phases, aligning with the aircraft’s transition from manufacturing to commercial deployment. The partnership aims to provide ePlane with a scalable digital infrastructure to support its long-term operational growth. Bayosthiti AI, Narayana Health partner to develop AI model for early detection of heart disease Bengaluru-based Bayosthiti AI, an innovator in AI-driven healthcare and molecular diagnostics, has partnered with Narayana Health, one of the world’s largest cardiac care networks, to co-develop artificial intelligence models capable of predicting cardiovascular disease in Indian patients at an early stage. The collaboration will combine Bayosthiti’s proprietary BIRT (Bayosthiti Intelligent RNA Transcriptomics) platform with Narayana Health’s extensive clinical data to create AI models trained on RNA sequencing, a process that reads active molecular instructions within cells. By decoding these cellular messages, the partners aim to identify subtle biological patterns linked to coronary artery disease—well before conventional diagnostics reveal symptoms. As part of the study, researchers at the Narayana Institute of Cardiac Sciences in Bengaluru will analyse transcriptomic data from over 12,000 participants. Each participant’s complete RNA profile, derived from blood samples, will be sequenced and fed into Bayosthiti’s AI systems to detect molecular signatures of heart disease. (Edited by Jyoti Narayan)
